Chemotherapy induced nausea and vomiting prevention and treatment

Australian Family Physician

Volumn 36, Issue 9, 2007, Pages 702-706

  Feeney, Kynan ^a   Cain, Michael ^a   Nowak, Anna K ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; NEUROKININ 1 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; DRUG EFFECT; GENERAL PRACTICE; HUMAN; METHODOLOGY; NAUSEA; NEOPLASM; REVIEW; VOMITING;

ADRENAL CORTEX HORMONES; ANTIEMETICS; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; HUMANS; NAUSEA; NEOPLASMS; RECEPTORS, NEUROKININ-1; SEROTONIN UPTAKE INHIBITORS; VOMITING;

EID: 36048953778     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 2006;24:4472-8.
2. Jordan K, Kasper C, Schmoll H, et al. Chemotherapy induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 2005;41:199-205.
3. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: antiemesis. Version 2. Jenkintown, PA: NCCN, 2006. Available at www.nccn.org/professionals/physician_gls/PDF/antiemesis. pdf.
4. Roscoe JA, Bushunow P, Morrow GR, et al. Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 2004;101:2701-8.
5. Roila F, Ballatori E, Ruggeri B, et al. Dexamethsone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med 2000;342:1554-9.
6. Olver IN. Aprepitant in antiemetic combinations to prevent chemotherapy induced nausea and vomiting. Int J Clin Pract 2004;58:201-6.
7. Warr DG, Hesketh PJ, Gralla RJ, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol 2005;23:2822-30.
8. Kris MG, Hesketh PJ, Somerfield MR. American Society of Clinical Oncology Guideline for antiemetics in oncology: update 2006. J Clin Oncol 2006;24:2932-47.